References
- Social, Health and Fam ily Affairs Committee of the Parliamentary Assembly of the Council of Europe. Hearing on “The handling of the Hi Ni pandemic: more transparency needed?” Strasbourg, 26 January 2010. Statement presented by Dr Wolfgang Wodarg http://www.assembly.coe.int/Comm itteeDocs/2010/20100126_Statement%20Wodarg.pdf (accessed 24 February 2010)
- World Health Organization. Pandemic (Hi Ni) 2009- update 87. http://www.who.int/csr/don/2010_02_12/en/print.htm I (accessed 24 February 2010)
- National Institute for Communicable Diseases. Situation update pandemic influenza A(H1N1) 2009–2010, South Africa. http://www.nicd.ac.za (accessed 24 February 2010)
- Hancock K, Veguilla V, Lu X, etal. Cross-reactive antibody responses to the 2009 pandemic Hi Ni influenza virus. N Engl J Med 2009; 361(20): 1945–1952
- Pérez-Trallero E, Pineiro L, Vicente D, Montes M, Cilia G. Residual immunity in older people against influenza A (H1N1) - recent experience in Northern Spain. Euro Surveill 2009; 14(39): 19344
- lkonen N, Strengell M, Kinnunen L, et aL High frequency of cross-reacting antibodies against 2009pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010; 15(5): 19478
- WHO 2010. Update on oseltamivir-resistance pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec 2010; 6(85): 37–48
- Kidd IM, Down J, Nastouli E, etal. Hi Ni pneumonitis treated with intravenous zanamivir. Lancet 2009; 374(9694): 1036
- Birnkrant D, Cox E. The Emergency Use Authorization of peramivir for treatment of 2009 Hi Ni influenza. N Engl J Med 2009; 361(23): 2204–2207
- Jefferson T, Foxlee R, Del Mar C, etal. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009; 339: b3675: 1–10
- Cowling BJ, Chan KH, Fang VJ, et aL Facemasks and hand hygiene to prevent influenza transmis-sion in households: a cluster randomized trial. Ann Intern Med 2009; 151(7): 437–446
- Cruz-Pacheco G, Duran L, Esteva L, et aL Modelling of the influenza A(H1N1)v outbreak in Mexico City, April-May 2009, with control sanitary measures. Euro Surveill 2009; 14(26): 19254
- Schoub BD. Recommendations pertaining to the use of viral vaccines: influenza 2010. S Afr Med J 2010; 100(2): 88–89
- Garten RJ, Davis CT, Russell CA, etal. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325(5937): 197–201
- Ilyushina NA, Kim JK, Negovetich NJ, etal. Extensive mammalian ancestry of pandemic (Hi Ni) 2009 virus. Emerg Infect Dis 2010; 16(2): 314–317
- Le OM, Wertheim HF, Iran ND, eta!, Horby P; Vietnam Hi Ni Investigation Team. A community cluster of oseltamivir-resistant cases of 2009 Hi Ni influenza. N Engl J Med 2010; 362(1): 86–87
- Besselaar TG, Naidoo D, Buys A, etal. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 2008; 14(11): 1809–1810
- WHO 2010. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 2010; 4(85): 21–28
- WHO 2010. Update on human cases of highly pathogenic avian influenza A (H5N1) infection: 2009. Wkly Epidemiol Rec 2010; 7(85): 49–56